Retinal Vasculometry Associations with Cardiometabolic Risk Factors in the European Prospective Investigation of Cancer-Norfolk Study. by Owen, CG et al.
Retinal Vasculometry Associations with
Cardiometabolic Risk Factors in the
European Prospective Investigation of
CancerdNorfolk Study
Christopher G. Owen, PhD,1 Alicja R. Rudnicka, PhD,1 Roshan A. Welikala, PhD,2 M. Moazam Fraz, PhD,3
Sarah A. Barman, PhD,2 Robert Luben, MSc,4 Shabina A. Hayat, PhD,4 Kay-Tee Khaw, FRCP,4
David P. Strachan, MD,1 Peter H. Whincup, FRCP,1 Paul J. Foster, FRCOphth5,6
Purpose: To examine associations between retinal vessel morphometry and cardiometabolic risk factors in
older British men and women.
Design: Retinal imaging examination as part of the European Prospective Investigation into CancerdNorfolk
Eye Study.
Participants: Retinal imaging and clinical assessments were carried out in 7411 participants. Retinal images
were analyzed using a fully automated validated computerized system that provides novel measures of vessel
morphometry.
Methods: Associations between cardiometabolic risk factors, chronic disease, and retinal markers were
analyzed using multilevel linear regression, adjusted for age, gender, and within-person clustering, to provide
percentage differences in tortuosity and absolute differences in width.
Main Outcomes Measures: Retinal arteriolar and venular tortuosity and width.
Results: In all, 279 802 arterioles and 285 791 venules from 5947 participants (mean age, 67.6 years;
standard deviation [SD], 7.6 years; 57% female) were analyzed. Increased venular tortuosity was associated with
higher body mass index (BMI; 2.5%; 95% conﬁdence interval [CI], 1.7%e3.3% per 5 kg/m2), hemoglobin A1c
(HbA1c) level (2.2%; 95% CI, 1.0%e3.5% per 1%), and prevalent type 2 diabetes (6.5%; 95% CI, 2.8%e10.4%);
wider venules were associated with older age (2.6 mm; 95% CI, 2.2e2.9 mm per decade), higher triglyceride levels
(0.6 mm; 95% CI, 0.3e0.9 mm per 1 mmol/l), BMI (0.7 mm; 95% CI, 0.4e1.0 per 5 kg/m2), HbA1c level (0.4 mm; 95%
CI, e0.1 to 0.9 per 1%), and being a current smoker (3.0 mm; 95% CI, 1.7e4.3 mm); smoking also was associated
with wider arterioles (2.1 mm; 95% CI, 1.3e2.9 mm). Thinner venules were associated with high-density lipoprotein
(HDL) (1.4 mm; 95% CI, 0.7e2.2 per 1 mmol/l). Arteriolar tortuosity increased with age (5.4%; 95% CI, 3.8%e
7.1% per decade), higher systolic blood pressure (1.2%; 95% CI, 0.5%e1.9% per 10 mmHg), in females (3.8%;
95% CI, 1.4%e6.4%), and in those with prevalent stroke (8.3%; 95% CI, e0.6% to 18%); no association was
observed with prevalent myocardial infarction. Narrower arterioles were associated with age (0.8 mm; 95% CI,
0.6e1.0 mm per decade), higher systolic blood pressure (0.5 mm; 95% CI, 0.4e0.6 mm per 10 mmHg), total
cholesterol level (0.2 mm; 95% CI, 0.0e0.3 mm per 1 mmol/l), and HDL (1.2 mm; 95% CI, 0.7e1.6 mm per 1 mmol/l).
Conclusions: Metabolic risk factors showed a graded association with both tortuosity and width of retinal
venules, even among people without clinical diabetes, whereas atherosclerotic risk factors correlated more
closely with arteriolar width, even excluding those with hypertension and cardiovascular disease. These nonin-
vasive microvasculature measures should be evaluated further as predictors of future cardiometabolic
disease. Ophthalmology 2019;126:96-106 Crown Copyright ª 2018 Published by Elsevier Inc. on behalf of the
American Academy of Ophthalmology. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Supplemental material available at www.aaojournal.org.Cardiovascular disease (CVD), including coronary heart
disease (CHD), heart failure, and stroke, is responsible for a
substantial burden of morbidity and disability.1 Type 2
diabetes is an increasing public health problem, affecting 1
in 10 adults globally, and a major cause of premature death
and morbidities, especially CVD.2 Early detection and96 Crown Copyright ª 2018 Published by Elsevier Inc. on behalf of the Ame
Academy of Ophthalmology. This is an open access article under the CC
(http://creativecommons.org/licenses/by/4.0/).prevention both of CVD and type 2 diabetes is key to
limiting future morbidity and mortality.3,4 Although disease
risk factors for type 2 diabetes, such as blood glucose and
hemoglobin A1c (HbA1c) levels, are yet to show good
screening performance,5 established markers of early
vascular disease are used in risk prediction models torican
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medical or lifestyle interventions to alter disease
trajectory.6,7 There have been a number of attempts to
improve the performance of these risk prediction models by
adding other risk factors.6,7 However, the addition of novel
risk factors has added little to CHD prediction.8 Recent
evidence suggests that early markers for the presence of
vascular disease (as opposed to additional risk factors) are
needed to improve risk prediction for population screening.5,9
Detailed retinal vasculometry may offer such a marker.
Growing evidence suggests that morphologic features in
retinal vessels, in particular vessel width, are early physio-
logic markers of cardiometabolic risk and disease (as well as
other disease processes).10e13 Although strong evidence has
accrued for some of these associations, particularly associ-
ations with type 2 diabetes and CVD (and their related risk
factors), other associations have remained inconsistent. For
instance, wider arterioles have been associated with higher
levels of blood glucose, total cholesterol, triglycerides, and
inﬂammatory markers, but not in all studies.10,12 Similarly,
associations of venular width with blood pressure also have
been inconclusive,10 although recent evidence suggests
increased width associated with hypertension.14 Wider
venules also seem to be associated with diabetes, elevated
glycosylated hemoglobin (HbA1c), lower levels of high-
density lipoprotein, inﬂammatory markers, smoking, and
obesity.10e12 However, some inconsistencies in the pres-
ence or absence of these associations (perhaps because of
uncertainty caused by sample size) remain.11,12 Moreover,
in comparison with studies examining vessel width, asso-
ciations with vessel tortuosity have been studied little,15
especially in relation to metabolic markers, and may
provide further insight into vasculometry changes
associated with cardiometabolic risk. Large population
studies are needed to resolve these uncertainties and to
allow the comparative performance of width and tortuosity
associations to be gauged. However, the assessment of
retinal vessel morphometry from retinal images, even with
computerized assistance, so far has been heavily reliant on
subjective operator involvement, which is time consuming
and open to measurement error,16 limiting its use in large-
scale preventative initiatives in a community setting. We
have developed a fully automated system for examining
retinal vessel size and tortuosity that overcomes many of
these difﬁculties.17e19 We have used this system to examine
the associations between cardiometabolic risk factors and
retinal vascular characteristics in a large prospective popu-
lation study of older British men and women to conﬁrm
associations previously reported with vessel width and to
provide novel associations with measures of vessel
tortuosity.Methods
Study Population
The European Prospective Investigation into Cancer (EPIC) study
is a European-based prospective cohort study designed to investi-
gate the cause of major chronic diseases.20 The United Kingdom
component of the study, EPICdNorfolk, recruited from generalpractices in and around the city of Norfolk and examined 25 639
participants (99.7% white European) 40 to 79 years of age at
baseline between 1993 and 1997 (response rate, 33%).21,22 Study
participants underwent a detailed examination (including anthro-
pometry, blood pressure, urine and venous blood sampling) and
questionnaire assessment at entry (including information on pre-
existing CVD, type 2 diabetes, and other medical conditions) and
completed periodic questionnaires about their health (with a
particular focus on dietary habits). Participants have been followed
up over a 13-year period for morbidity and mortality. In addition to
questionnaire data, participants were invited for further clinical
examinations over this period, including repeat anthropometric
assessment, venous blood sampling, retinal imaging, and physio-
logic measures.22
Third Follow-up
Between 2004 and 2011, 8623 participants provided updated in-
formation on medical history and lifestyle behavior.22 Weight and
height were measured with participants in light clothing without
shoes. Weight was measured to the last 0.1 kg using regularly
calibrated digital scales (Tanita TBF-300; Tanita UK Ltd., Mid-
dlesex, United Kingdom), and height was measured to the last
complete 0.1 cm using a stadiometer (Chasmors, London, United
Kingdom). Body mass index (BMI) was calculated as weight in
kilograms per height in square meters. Seated blood pressure was
measured twice using an automated blood pressure monitor
(Accutorr PlusTM; Datascope Patient Monitoring, Huntington,
United Kingdom); the mean of both measures was used. A non-
fasting venous blood sample was collected; details of the analytic
measures have been published previously.22 Hemoglobin A1c was
measured in whole blood using high-performance liquid chroma-
tography. Serum total cholesterol and HDL cholesterol were
measured using an autoanalyzer (RA 1000 Technicon; Bayer
Diagnostics, Basingstoke, United Kingdom). Low-density
lipoprotein (LDL) cholesterol was calculated using the
FredricksoneFriedewald equation.23
Ocular Examination
Ocular assessment included measurement of vision, visual acuity
(in logarithm of the minimum angle of resolution units), and
closed-ﬁeld autorefraction (Humphrey model 500; Humphrey
Instruments, San Leandro, CA). Macular-centered 45 digital
fundus photographs were obtained using a TRC-NW6S
nonmydriatic retinal camera and an IMAGEnet Telemedicine
System (Topcon Corporation, Tokyo, Japan) with a
10-megapixel Nikon D80 camera (Nikon Corporation, Tokyo,
Japan) without pharmacologic dilation of the pupil. Image pro-
cessing was carried out using an automated computerized system
(QUantitative Analysis of Retinal vessel Topology and siZe
[QUARTZ] London, UK).17e19 The automated system distin-
guishes between right and left eyes (by optic disc localization)
and between venules and arterioles, identiﬁes vessel segments,
outputs centerline coordinates, and measures vessel width and
angular change between vessel centerline coordinates, as well as
providing further measures of tortuosity.17e19,24 An ensemble
classiﬁer of bagged decision trees (with color information) was
used to classify vessels as being either venules or arterioles.
Only vessels that were classiﬁed with 80% or more probability
were retained to balance the number of venules and arterioles
detected, as well as to maximize the number of vessels included
for analyses.18 The performance of the arteriole/venule detection
program was veriﬁed manually in a subset of images and showed
detection rates of 84% for arterioles and 77% for venules
and corresponding false-positive rates of 23% and 16%,97
Ophthalmology Volume 126, Number 1, January 2019respectively.18 An automated assessment of image quality also
was made based on the segmented vasculature.18 The system
obtains thousands of measures of width and tortuosity from
the entire retinal image (dependent on image quality), not just
concentric areas centered on the disc.10 These measures
were summarized using mean width in micrometers and
tortuosity with arbitrary units, weighted by segment length,
for arterioles and venules separately for each image. In the
case of multiple images per person, an automated algorithm
developed to assess image quality allowed the best right eye
and best left eye images to be selected for analyses. A
previously validated tortuosity measure that shows good
agreement with subjective assessment of vessel tortuosity,
based on the mean change in chord length between successive
divisions of the vessel, was used.24 System performance has
been outlined in detail and validated previously and allows
automated batch processing of images from large population-
based studies.17e19 A model eye was used to quantify the
magniﬁcation characteristics of the telecentric fundus camera
used (Topcon TRC-NW6S), allowing pixel dimensions of vessel
width to be converted to real size.25Ethics, Governance, and Consent
The EPICeNorfolk Eye Study was carried out according to the
tenets of the Declaration of Helsinki and the Research Governance
Framework for Health and Social Care. The study was approved by
the Norfolk Local Research Ethics Committee (identiﬁer, 05/
Q0101/191) and East Norfolk and Waveney National Health Ser-
vice Research Governance Committee (identiﬁer, 2005EC07L).
All participants gave written informed consent.Statistical Analysis
Statistical analyses were carried out using STATA software
version 13 (StataCorp LP, College Station, TX). Segment-wise
weighted mean widths and tortuosity were used to provide a
measure for venules and arterioles separately for each eye. His-
tograms of retinal vessel widths showed normal distributions,
whereas measures of tortuosity were skewed positively and log-
transformed. Multilevel linear regression models adjusting for
age and gender were used to examine associations of
cardiometabolic risk factors and prevalent disease status with
retinal vessel morphometry outcomes, allowing for repeated
measures of vessel indices within the same person. Regression
models provided mean differences in width and percentage dif-
ferences in tortuosity for venules and arterioles separately, per
decade in age, women versus men, current smokers and former
smokers versus never smokers, or per-unit increase in
cardiometabolic risk factor (per 5-kg/m2 increase in BMI; per
10-mmHg increase in systolic and diastolic blood pressure; per
1-mmol/l increase in total cholesterol, low-density lipoprotein,
high-density lipoprotein, or triglyceride levels; and per 1% in-
crease in HbA1c level). For disease outcomes, differences in
vessel indices were obtained comparing those with prevalent
disease present (including type 2 diabetes, myocardial infarction,
stroke, and known or treated hypertension) versus absent. Dif-
ferences in associations between men and women were examined
formally by inclusion of an interaction term between the risk
factor and gender into the regression model. Risk factors found to
be statistically signiﬁcantly related to vascular measures at the 5%
level were included subsequently in mutually adjusted models.
We also examined associations after exclusion of participants
with prevalent disease outcomes.98Results
Of 18 380 individuals invited to participate in this phase of the
study, 8623 (47%) took part (mean age, 67.6 years; 57% women).
Figure S1 (available at www.aaojournal.org) shows a ﬂow diagram
of the numbers participating in the study. Fundus imaging and
refractive assessment were carried out in 7411 individuals, of
whom 5957 participants (80%) had at least 1 image of sufﬁcient
quality and classiﬁed vessels as arterioles or venules with a
probability set at 80% detection. It was not possible to obtain
useful data from the remainder because images were
miscentered, were defocussed, or were obstructed by lashes,
media opacities, or both. A small number had missing data for
height, weight, or blood pressure (n ¼ 10), leaving 5947
participants with measures of vessel width and tortuosity for
565 593 vessel segments (279 802 arterioles and 285 791
venules) from 10 474 images; blood sample data were available
for 5514 participants. Characteristics of EPIC participants at
baseline and those who took part in the third health examination
with and without useable fundus images have been described
previously.26 Those attending the third health examination were
younger at baseline, were of higher BMI and socioeconomic
status, and were less likely to be a current smoker compared
with participants who were not followed up.26 Participant
characteristics of EPIC participants who took part in the third
health examination and who were included in the analyses
compared with those who were not (5947 vs. 2676 participants)
are summarized in Table 1. Other than those included being
slightly younger (mean age, 68 years vs. 71 years), there was no
clear evidence of a systematic difference in third health
examination participant characteristics. Retinal vessel
morphometry features in those with useable fundus images also
are summarized for arterioles and venules separately. Histograms
of arteriolar and venular width and tortuosity measures (with and
without log transformation) are shown in Figure S2 (available at
www.aaojournal.org) and show appreciable variation in these
measures within this study population.
Differences in retinal vessel width in micrometers and per-
centage differences in tortuosity by type 2 diabetes and CVD risk
factors and outcomes are shown by vessel type in Table 2.
Arterioles were associated inversely and were more tortuous with
older age (mean difference, 0.8 mm [95% CI, 0.6e1.0 mm] and
5.4% [95% CI, 3.8%e7.1%] per decade, respectively). Wider
venules were observed with older age (mean difference, 2.6 mm;
95% CI, 2.2e2.9 mm per decade) and among current smokers
compared with never smokers (mean difference, 3.0 mm; 95%
CI, 1.7e4.3 mm). Narrower arterioles (mean difference, 0.5 mm;
95% CI, 0.2e0.8 mm) and more tortuous arterioles and venules
were associated strongly with female gender compared with male
gender (pecentage difference, 3.8% [95% CI, 1.4%e6.4%] and
2.2% [95% CI, 0.7%e3.6%], respectively).
Retinal Vasculometry Associations with
Metabolic Risk Factors
Venular width was associated positively with type 2 diabetes risk
factors, including higher BMI (mean difference, 0.7 mm; 95% CI,
0.4e1.0 mm per 5 kg/m2) and HbA1c level (mean difference, 0.4
mm; 95% CI, e0.1 to 0.9 mm per 1%). Wider venules also were
associated positively with elevated levels of triglycerides (mean
difference, 0.6 mm; 95% CI, 0.3e0.9 mm per 1 mmol/l). Venular
tortuosity also was associated positively with type 2 diabetes risk
factors, as well as prevalent type 2 diabetes. Venules were 2.5%
more tortuous (95% CI, 1.7%e3.3%) per 5-kg/m2 increase in BMI,
2.2% more tortuous (95% CI, 1.0%e3.5%) per 1% rise in HbA1c
Table 1. Participant Characteristics of European Prospective Investigation of Cancer Participants Who Took Part in the Third Health
Examination with and without Useable Fundus Images (5947 Participants vs. 2676 Participants)
Characteristic
Third Health Examination
Included in the Analyses Excluded from the Analyses
No. of participants 5947 2676
Mean age (SD), yrs 67.6 (7.6) 71.3 (8.6)
Female gender, no. (%) 3393 (57) 1365 (51)
Current smokers, no. (%) 267 (4.5) 107 (4.0)
Former smoker, no. (%) 2628 (44) 1284 (48)
Mean height (SD), cm 166.4 (9.1) 166.2 (9.2)
Mean weight (SD), kg 74.4 (14.3) 74.6 (14.0)
Mean BMI (SD), kg/m2 26.8 (4.3) 27.0 (4.2)
Mean systolic blood pressure (SD), mmHg 135.7 (16.6) 137.3 (16.8)
Mean diastolic blood pressure (SD), mmHg 78.4 (9.2) 77.9 (9.6)
Mean total cholesterol (SD), mmol/l 5.4 (1.1) 5.3 (1.1)
Mean LDL cholesterol (SD), mmol/l 3.2 (1.0) 3.1 (1.0)
Mean HDL cholesterol (SD), mmol/l 1.5 (0.4) 1.5 (0.4)
Mean triglycerides (SD), mmol/l 1.7 (0.9) 1.6 (0.9)
HbA1c (SD), % 5.8 (0.6) 5.9 (0.7)
Mean HbA1c, mmol/mol 40 41
Prevalent MI, no. (%) 187 (3.1) 106 (4.0)
Prevalent stroke, no. (%) 118 (2.0) 67 (2.5)
Prevalent type 2 diabetes, no. (%) 237 (4.0) 156 (5.8)
Mean axial length (SD), mm 23.6 (1.2) 23.5 (1.2)
Mean best vision sphere (SD), diopters 0.2 (2.2) 0.2 (2.3)
Mean arteriolar width (SD), mm 74.8 (6.9) d
Mean venular width (SD), mm 88.4 (11.3) d
Arteriolar tortuosity  1000* 4.2 (1.6) d
Venular tortuosity  1000* 3.3 (1.3) d
BMI ¼ body mass index; HbA1c ¼ hemoglobin A1c; HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein; MI ¼ myocardial infarction;
SD ¼ standard deviation; d ¼ missing data.
Units of tortuosity are arbitrary. For participants included in the analyses, the extent of missing data is as follows: total cholesterol missing data for 429
participants, LDL cholesterol missing data for 511 participants, HDL cholesterol missing data for 428 participants, triglycerides missing data for 429 par-
ticipants, and HbA1c missing data for 498 participants.
*Geometric mean (SD).
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those with type 2 diabetes compared with those without.Retinal Vasculometry Associations with
Cardiovascular Risk Factors
Arteriolar widths were associated inversely with age, systolic blood
pressure (mean difference, 0.5 mm; 95% CI, 0.4e0.6 mm per 10-
mmHg rise), and diastolic blood pressure (mean difference, 1.0
mm; 95% CI, 0.9e1.2 mm per 10-mmHg rise). Arteriolar tortuosity
also was associated positively with systolic blood pressure (per-
centage difference, 1.2%; 95% CI, 0.5%e1.9% per 10-mmHg,
respectively). Arteriolar width was associated inversely with total
cholesterol (mean difference, 0.2 mm; 95% CI, 0.0e0.3 mm per 1
mmol/l) and HDL cholesterol (mean difference, 1.2 mm; 95% CI,
0.7e1.6 mm per 1 mmol/l). Narrower venules and decreased ven-
ular tortuosity were associated with HDL cholesterol (percentage
difference, 1.4 mm [95% CI, 0.7e2.1 mm] and 1.8% [95% CI,
e0.1% to 3.7%] less tortuosity per 1 mmol/l). No associations were
observed with prevalent myocardial infarction, but there was a
suggestion of increased arteriolar tortuosity with prevalent stroke
(percentage difference, 8.3%; 95% CI, e0.6% to 18%). Arterioles
were narrower and more tortuous with increasing age; venular
width increased with age. Both vessel types were wider among
smokers compared with lifelong never smokers. Figure 1 shows the
associations between retinal vessel indices and type 2 diabetes andCVD risk factors by quintile; statistically signiﬁcant associations
seemed to be graded. These associations remained after
exclusion of those with prevalent disease, including myocardial
infarction, stroke, and diabetes (n ¼ 466).
Sensitivity and Multivariate Analyses
Sensitivity analyses examined the differences in vessel width and
tortuosity associated with cardiometabolic risk factors, excluding
those with clinical diabetes or CVD and those with known or
treated hypertension (data available on request). Metabolic asso-
ciations with venular width and tortuosity persist after exclusion of
those with clinical diabetes, and arteriolar width associations with
vascular risk factors (particularly blood pressure) remain after
excluding those with CVD and hypertension. Retinal vessel asso-
ciations were similar in men and women (P > 0.05, tests for
interaction), except for HDL cholesterol, for which opposing
associations with arteriolar tortuosity were apparent. Per 1-mmol/l
higher HDL cholesterol, arteriolar tortuosity was 5.8% (95% CI,
0.1%e11.8%) higher in men, but 4.0% (95% CI, 0.0%e7.8%)
lower in women (P ¼ 0.006, test for interaction).
The mutual independence of these risk-factor associations also
was examined. Mutually adjusted risk-factor associations are
presented in Table S1 (available at www.aaojournal.org). Risk
factors that were statistically signiﬁcantly associated with retinal
vasculometry in Table 2 were included in multivariate regression
models. Associations with both arteriolar morphometry measures99
Table 2. Difference in Vessel Width and Tortuosity Associated with Type 2 Diabetes and Cardiovascular Disease Risk Factors and Outcomes for Individual Factors in Multivariate
Regression Models Adjusted for Age and Gender
Risk Marker
Arteriolar Width (mm) Venular Width (mm) Arteriolar Tortuosity (%) Venular Tortuosity (%)
Difference (95% Conﬁdence
Interval) P Value
Difference (95% Conﬁdence
Interval) P Value
Difference (95% Conﬁdence
Interval) P Value
Difference (95% Conﬁdence
Interval) P Value
Per decade in age e0.79 (e1.00 to e0.58) <0.001 2.56 (2.20e2.91) <0.001 5.44 (3.80e7.11) <0.001 e0.23 (e1.15 to 0.69) 0.619
Female vs. male e0.51 (e0.83 to e0.19) 0.002 e0.32 (e0.86 to 0.22) 0.245 3.83 (1.37e6.35) 0.002 2.16 (0.74e3.60) 0.003
Current vs. never smoked 2.13 (1.34e2.91) <0.001 3.03 (1.71e4.34) <0.001 e2.70 (e8.22 to 3.16) 0.360 1.66 (e1.75 to 5.18) 0.345
Former vs. never smoked 0.11 (e0.23 to 0.44) 0.522 0.31 (e0.25 to 0.87) 0.275 e0.21 (e2.67 to 2.31) 0.870 0.88 (e0.58 to 2.36) 0.240
Per 5 kg/m2 in BMI 0.15 (e0.03 to 0.34) 0.098 0.72 (0.41e1.03) <0.001 e0.24 (e1.59 to 1.13) 0.729 2.52 (1.71e3.34) <0.001
Per 10 mmHg in SBP e0.50 (e0.60 to e0.41) <0.001 e0.06 (e0.23 to 0.10) 0.458 1.20 (0.47e1.94) 0.001 0.45 (0.02e0.88) 0.039
Per 10 mmHg in DBP e1.04 (e1.22 to e0.87) <0.001 e0.32 (e0.61 to e0.02) 0.035 0.75 (e0.56 to 2.07) 0.263 e0.55 (e1.30 to 0.21) 0.157
Per 1 mmol/l in TC e0.18 (e0.33 to e0.02) 0.024 e0.16 (e0.41 to 0.10) 0.233 0.42 (e0.72 to 1.58) 0.472 e0.52 (e1.18 to 0.15) 0.131
Per 1 mmol/l in LDL e0.09 (e0.26 to 0.08) 0.313 e0.24 (e0.53 to 0.05) 0.108 0.60 (e0.69 to 1.90) 0.362 e0.39 (e1.14 to 0.36) 0.310
Per 1 mmol/l in HDL e1.18 (e1.62 to e0.74) <0.001 e1.42 (e2.16 to e0.69) <0.001 e0.61 (e3.82 to 2.70) 0.714 e1.83 (e3.70 to 0.07) 0.059
Per 1 mmol/l in triglycerides 0.06 (e0.12 to 0.23) 0.524 0.57 (0.27e0.86) <0.001 0.29 (e1.01 to 1.62) 0.661 e0.18 (e0.94 to 0.59) 0.647
Per 1% in HbA1c per 0.22 (e0.08 to 0.51) 0.148 0.41 (e0.07 to 0.90) 0.097 0.95 (e1.21 to 3.15) 0.393 2.24 (0.96e3.53) 0.001
Prevalent MI vs. absent 0.66 (e0.27 to 1.58) 0.165 1.20 (e0.35 to 2.75) 0.129 4.36 (e2.57 to 11.77) 0.224 1.87 (e2.14 to 6.05) 0.366
Prevalent stroke vs. absent 0.79 (e0.37 to 1.95) 0.181 0.59 (e1.35 to 2.53) 0.553 8.30 (e0.59 to 17.99) 0.068 3.66 (e1.42 to 9.01) 0.161
Prevalent DM vs. absent e0.08 (e0.90 to 0.75) 0.857 0.48 (e0.90 to 1.86) 0.494 1.64 (e4.38 to 8.03) 0.602 6.53 (2.78e10.41) 0.001
BMI ¼ body mass index; DBP ¼ diastolic blood pressure; DM ¼ diabetes mellitus; HbA1c ¼ hemoglobin A1c; HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein; MI ¼ myocardial infarction;
SBP ¼ systolic blood pressure; TC ¼ total cholesterol.
Total number of patients included: 5942. Regression coefﬁcients are from a multilevel model allowing for repeated images from the same person (random effect for person) and adjusting for age and gender as
ﬁxed effects. Prevalent MI, stroke, and DM: n ¼ 187, n ¼ 118, and n ¼ 238, respectively. For participants included in the analyses, the extent of missing data is as follows: TC missing data for 429
participants, LDL cholesterol missing data for 511 participants, HDL cholesterol missing data for 428 participants, triglycerides missing data for 429 participants, and HbA1c missing data for 498 participants.
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Figure 1. Box-and-whisker plots showing adjusted mean vessel width and tortuosity by quintiles of cardiovascular and type 2 diabetes risk factors for venues
and arterioles. Adjusted means (solid square symbols), 95% conﬁdence intervals (CIs; error bars), regression lines (solid line), and associated 95% CIs
(dashed lines) are from a multilevel model allowing for age, gender, and repeated-measure of vessel indices within each person. BMI ¼ body mass index;
BP ¼ blood pressure; HbA1c ¼ hemoglobin A1c; HDL ¼ high-density lipoprotein; LDL ¼ low-density lipoprotein.
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Figure 1. (continued).
Ophthalmology Volume 126, Number 1, January 2019and cardiometabolic risk factors remained remarkably stable.
Consistent associations were observed between arteriolar width
and age, current smoking status, blood pressure, and HDL
cholesterol, but there was no evidence of an independent
association with total cholesterol. Similarly strong associations
remained for arteriolar tortuosity with age, gender, and blood
pressure. Associations from mutually adjusted models for venular
measures also were remarkably similar to the associations
presented in Table 2. Venular width associations with age,
current smoking status, BMI, and diastolic blood pressure were
relatively unchanged, but associations with HDL cholesterol and
triglyceride levels were attenuated toward the null. Further
investigation showed that associations with lipids were
confounded primarily by BMI. Venular tortuosity associations
with gender and BMI were relatively unchanged. However, the
association with HbA1c level was attenuated (1.3% [95% CI,
0.0%e2.6%] increase in venular tortuosity per 1% increase in
HbA1c level), and the association with systolic blood pressure
was weakened by adjustment for BMI. Multilevel regression
models adjusting for age, gender, and blood pressure showed a
stronger association with prevalent stroke than in Table 2, with
9.0% more tortuous arterioles among those who had experienced
a stroke compared with those who had not (95% CI, 0.1%e
18.8%; P < 0.001), suggesting that the effect on arteriolar102tortuosity is independent of systolic blood pressure. Increased
venular tortuosity among those with prevalent diabetes was
independent of gender, BMI, and blood pressure (percentage
difference, 5.5%; 95% CI, 1.4%e8.9%).
Discussion
Our results are consistent with previously documented
retinal vasculometry associations with type 2 diabetes and
CVD risk factors and outcomes,10e13 but provide further
insight where uncertainties over the presence or absence of
associations exist. Moreover, novel associations with vessel
tortuosity provide further evidence of vasculometry
changes. Findings suggest that type 2 diabetes risk factors
and prevalent type 2 diabetes are associated with the
morphologic features of retinal venules, both in terms of
width and tortuosity, whereas coronary risk factors have a
greater inﬂuence on arteriolar width. These associations
remain after exclusion of those with prevalent diabetes, with
CVD, and with known or treated hypertension, suggesting
that these vessel changes may be indicative of preclinical
phases of disease.
Owen et al  Retinal Vasculometry and Cardiometabolic RiskAlthough retinal signs of diabetic eye disease are well
described,27 there have been some uncertainties about the
association between diabetes, particularly risk factors for
type 2 diabetes, and retinal vessel morphometry features,
with inconsistencies between cross-sectional and longitudi-
nal ﬁndings.28 However, a recent meta-analysis showed that
wider venules, but not arterioles, were associated with
diabetes,29 consistent with cross-sectional observations
suggesting that wider venules are associated with increasing
levels of fasting glucose and HbA1c levels.28 Findings from
the present study are consistent with these risk factor
observations, not only replicating the associations between
increased venular width and HbA1c level (although not
formally statistically signiﬁcant), but also showing
coherent associations with other metabolic risk factors,
including BMI, as well as novel associations with levels
of triglycerides, associations that were absent with
arteriolar width. The present study also showed that
narrow venules were associated with increased HDL
cholesterol levels, which when considered in relation to
triglyceride levels, may be considered as a further
indicator of insulin resistance.30 However, venular width
associations with HDL cholesterol and triglyceride levels
were weakened after multivariate adjustment, and
associations between HDL cholesterol and tortuosity
differed in men and women. Reasons for these gender-
associated differences are unclear, but may relate to
gender differences observed in associations between retinal
width and CHD, where associations are evident in women
and not in men.13,31 Moreover, this study was novel in
showing consistent metabolic associations with retinal
vessel tortuosity, whereby increased venular tortuosity was
associated with type 2 diabetes risk factors (including levels
of BMI and HbA1c), in addition to showing a strong as-
sociation with prevalent type 2 diabetes. These associations
persist after mutual adjustment and exclusion of those with
clinical diabetes, suggesting that these associations may be
independent early markers of the disease process. Associa-
tions observed in this study seem to contrast with those
observed with overt disease, whereby arteriolar (not ven-
ular) tortuosity has been related to the duration of diabetes.32
Associations with type 2 diabetes risk markers (including
BMI and HbA1c level), as well as other cardiovascular
risk factors (systolic blood pressure and blood
cholesterol), were not observed among this diseased
group.32 This may suggest differences in retinal vessel
morphometry feature associations between disease
development and overt disease.
Cross-sectional and longitudinal associations between
retinal vasculometry and CVD outcomes have been stud-
ied, including CHD, stroke, and cardiovascular mortal-
ity.13,33e35 However, more recent evidence from
prospective studies has raised some inconsistencies. In
particular, retinal vessel caliber changes are associated with
CHD events only in women, not men,13,31 and in some
studies, vessel width associations with stroke seem to be
apparent only in venules, which seems to contradict the
perceived disease process.36 In the present study, we
observed no association between retinal vascular width
measures and prevalent CHD, although there was thesuggestion of a positive association between arteriolar
tortuosity and prevalent stroke, which was stronger after
adjustment for age, gender, and blood pressure. An
association between narrower arterioles and high blood
pressure has been well documented.10,11,14,37 The present
study conﬁrmed these ﬁndings, showing decreased arteri-
olar width associated with both increased systolic and
diastolic blood pressure.
Evidence examining associations between venular width
and blood pressure have been less consistent,10 although a
recent meta-analysis suggested increased width associated
with hypertension.14 Our study showed a small but
statistically signiﬁcant decrease in venular width with
increasing diastolic blood pressure that remained after
multivariate adjustment, although the magnitude of
association was less than the association observed with
arterioles. This association was no longer statistically
signiﬁcant when those with prevalent CVD and known or
treated hypertension were excluded, but associations with
systolic blood pressure remained. The observation of an
association between vessel width and systolic blood
pressure among those without hypertension strengthens the
potential additional use of retinal vessel morphometry
assessment in routine health checks. Of particular note
were the different associations with vessel tortuosity,
where increased arteriolar and venular tortuosity was
associated with greater systolic blood pressure (but not
diastolic blood pressure), whereas decreased venular
tortuosity was associated with higher HDL cholesterol
level. The apparent different direction of associations with
these cardiovascular risk factors potentially are consistent
and replicate ﬁndings observed in another large
population-based study.15
By far the strongest associations observed were those
with age and smoking, where there was arteriolar narrowing
and increased tortuosity per decade rise in age and, with
current smoking, appreciable arteriolar and venular dilation.
There was also the suggestion of smaller arterioles and
markedly greater tortuosity (both arteriolar and venular) in
women compared with men. However, gender differences in
width largely were explained and differences in tortuosity
partially were explained by height (data not presented).
Although differences in CVD risk between men and women
may have contributed to these associations, explanations for
potential gender differences in retinal vessel morphometry
remain uncertain. The effect of age was independent of
blood pressure, as well as other cardiometabolic risk factors,
but smaller compared with a body of literature suggesting a
2- to 5-mm decrease in arteriolar width per decade in age
(although these later effect sizes were seen in relation to
central retinal vessel equivalent sizes, which are 2e3 times
larger because they are scaled up from retinal measures
obtained within 0.5 to 1.5 disc diameters from the disc).10,38
Nevertheless, these observations demonstrate the well-
known association between narrower, more tortuous arteri-
oles and older age.39 The vasodilatory effects of smoking
also have been reported widely in venules, less so in
arterioles.10 Increased carbon monoxide levels among
smokers may well provide a biological explanation for
these ﬁndings.40103
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so far have been heavily reliant on operator involvement,
which is subjective, open to measurement error, and time
consuming,16 limiting its use in large population-based
studies. The EPIC Eye Study is such a study that is richly
phenotyped, allowing examination of multiple CVD risk
factors within the same cohort. Our fully automated system
provides a rapid, detailed quantiﬁcation of retinal vascula-
ture in this population for both arterioles and venules
separately, because they show some opposing patterns of
association with risk markers and disease states.41 The
system has been validated extensively and was successful
in obtaining vessel measures in 4 of 5 persons who
underwent retinal imaging. It was not possible to obtain
useful data from the remainder because image quality was
graded as insufﬁcient (with the arteriole/venule detection
program unable to distinguish arterioles from venules),
with images being decentered, defocussed, or obstructed
by media opacities or lashes, an inevitable consequence of
nonmydriasis, especially in this older age group. This did
not seem to reﬂect a selection bias because there was no
evidence of marked differences in other phenotypes
between those with and without vessel measures.
Although those participating in the third health
examination did seem to be select (being signiﬁcantly
younger, with higher BMI, and of more privileged
socioeconomic status compared with participants at
baseline), this is unlikely to invalidate retinal vessel
morphometry feature and cardiometabolic risk factor
associations.42
Our image analysis system has improved performance
or is similar to earlier approaches,43e46 obtaining measures
from the entire retinal image, not just concentric areas
centered on the disc.10 Earlier studies have considered
effect sizes in relation to central retinal artery and central
retinal vein equivalents.10 It was not possible to compare
measures directly with central retinal artery and central
retinal vein equivalents because the number of measures
of width were considerably more and were located over
the entire image. Reducing the measurement area,
typically between 0.5 to 1.5 disc diameters, to provide
these measures would result in an enormous data
reduction that may exclude vessel changes occurring
elsewhere in the retina. Moreover, poor agreement
between different systems has been highlighted, making
direct comparisons in retinal caliber measures between
systems problematic.47 Despite this, we report similar
effect sizes (e.g., the change in vessel width associated
with smoking) in relation to a narrower mean width
indicative of a far greater measurement area. Vessel
density is not uniform across the retina.48 Figure S3
(available at www.aaojournal.org) shows the extent of
vessel measures in a typical image. Although the
measures are not constrained to concentric areas close to
the disc, as used in comparable systems,47 this was not
perceived as a weakness given that our system is fully
automated and does not allow for measurement areas to
be selected. Moreover, consistent inclusivity of measures
across the entire image was observed in all images that
were selected automatically as being of sufﬁcient quality104for inclusion, limiting any potential selection effects.19
Our approach is supported further by the ﬁrst study
examining the use of artiﬁcial intelligence in detecting
CVD, which seems to show that retinal vessels over their
entire length are key areas of interest in estimating
cardiovascular risk factors, such as age, blood pressure,
and HbA1c level.49 Although it is difﬁcult at present to
obtain precise information on how artiﬁcial intelligence
algorithms arrive at decisions, these ﬁndings suggest that
retinal vasculometry studies such as ours are key to
understanding processes associated with cardiometabolic
disease.
We have condensed these measures to provide an
overall summary of mean width, but it is possible that
relative changes in vessel indices over time and perhaps
variations in measures along the length of a vessel may be
stronger predictors of vascular health than absolute size,
although this remains to be established. The presence of
differential retinal vasculometry associations with
cardiometabolc risk factors underline the importance of
making separate arteriolar and venular width and
tortuosity measures, calling into question the validity of
arteriolar-to-venular ratio measures for cardiovascular risk
proﬁling.
The modest vasculometry association with prevalent
stroke and the absence of associations with prevalent
myocardial infarction does not necessarily mean that
retinal vasculometry measures are unlikely to have a role in
CVD risk prediction. Prevalent cases are likely to be very
different to premorbid incident cases, with established
cases often receiving vasoactive medications, which may
have a modifying effect on vascular morphometry. It is
also possible that there was insufﬁcient power to determine
change in these dichotomous outcomes, given the small
number of prevalent events within this study population.
However, retinal vessel associations with type 2 diabetes
risk markers and diabetes mellitus were observed, even
after exclusion of those with prevalent outcome, suggesting
that preclinical vasculometry changes are apparent. This is
commensurate with recent longitudinal evidence, raising
the possibility that retinal vasculometry may have a role in
risk prediction,50 as well as surveillance and disease
management. Power to determine change in continuous
outcomes was greater, replicating previous observations
and yielding a number of novel associations, particularly
those with vessel tortuosity, as well as metabolic
markers. However, given the cross-sectional nature of
data collection, these associations between cardiometabolic
risk factors and retinal vessel abnormalities do not of
themselves allow the potential role of retinal vessel quan-
tiﬁcation in disease risk prediction to be ascertained
formally. Future follow-up of this and other large cohorts
with high-quality retinal imaging data will allow this issue
to be investigated.
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